PTL-303

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePTL-303
Drug Alias NamePTL-303
ClassificationSmall molecules
Mechanisms of ActionCytokines modulators
TargetsCytokines
Therapy Area/IndicationsFibrosisLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPacific Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPacific Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsFibrosisLiver Cirrhosis

Other Information

ATC CodeN/A
Related LinksN/A